5Hertzman JC,Egyhazi BS.BRAF inhibitois in cancer therapy[J]. Pharmacol Ther,2014,142(2):176-182.
6Okamoto I.Epidermal growth factor receptor in relation to tumor development:EGFR-targeted anticancer therapy[J].FEBS J,2010,277(2):309-315.
7Roskoski R Jr.A historical overview of protein kinases and their targeted small molecule inhibitors[J].Pharmacol Res,2015,100:1-23.
8MacFarlane M,Williams AC.Apoptosis and disease:a life or death decision[J].EMBO Rep,2004,5(7):674-678.
9Talaiezadeh A,JaIali F,Galehdari H,et al.Time depended Bcl-2 inhibition might be useful for a targeted drug therapy[J].Cancer Cell Int,2015,15:105.
10Kontos CK,Christodoulou MI,Scorilas A.Apoptosis-related BCL2- family members:Key players in chemotherapy[J].Anticancer Agents Med Chem,2014,14(3):353-374.